Efficacy and safety of umbilical cord mesenchymal stem cells for the treatment of patients with COVID-19
CONCLUSION: Intravenous infusion of MSCs in patients with COVID-19 was effective and well tolerated. Further studies involving a large cohort or randomized controlled trials are warranted.
Source: Clinics - Category: General Medicine Source Type: research
More News: Allergy & Immunology | Chemistry | Computers | Coronavirus | COVID-19 | General Medicine | Hematology | International Medicine & Public Health | Laboratory Medicine | Outbreaks | Respiratory Medicine | SARS | Stem Cell Therapy | Stem Cells | Study